Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway.

Free Radic Biol Med

Dental Science Research Institute and the BK21 Project, Medical Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, 500-757, Republic of Korea. Electronic address:

Published: December 2013

Mammalian peroxiredoxin V (PrdxV) is a multifunctional protein that protects cells from DNA damage and inhibits stress-induced apoptosis. However, PrdxV is also known to be involved in modulating lipopolysaccharide (LPS)-induced host cell signaling, but its precise role is not fully understood. In this study, we used stably transfected RAW264.7 cells and transiently transfected 293-mTLR4-MD2-CD14 cells expressing wild-type (WT) or mutant (C48S) PrdxV to characterize the function and mechanism of action of PrdxV in LPS-induced immune responses. We found that PrdxV selectively reduces production of interleukin 6 (IL-6) by inhibiting activation of signal transducer and activator of transcription 5 (Stat5) through interaction with Jak2. Notably, this activity of PrdxV was dependent on its catalytic Cys48 residue, but not its peroxidase activity. The binding of to Jak2 effectively inhibited Jak2 phosphorylation, but PrdxV did not act as efficiently as SOCS1 (suppressor of cytokine signaling 1). Our results suggest that PrdxV is a key mediator contributing to the regulation of LPS/TLR4-induced immune responses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2013.06.038DOI Listing

Publication Analysis

Top Keywords

prdxv
8
immune responses
8
peroxiredoxin selectively
4
selectively regulates
4
regulates il-6
4
il-6 production
4
production modulating
4
modulating jak2-stat5
4
jak2-stat5 pathway
4
pathway mammalian
4

Similar Publications

Activation of the epidermal growth factor receptor (EGFR)/signal transducer and activator of transcription 3 (Stat3) signaling pathway has been reported to be associated with renal fibrosis. We have recently demonstrated that peroxiredoxin V (PrdxV) acted as an antifibrotic effector by inhibiting the activity of Stat3 in TGF-β-treated NRK49F cells. However, the underlying mechanism of PrdxV remains poorly understood.

View Article and Find Full Text PDF

Peroxiredoxin V: A candidate breast tumor marker of population specificity.

Mol Clin Oncol

May 2013

Department of Molecular Biology, Institute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan ;

Breast and cervical cancers account for approximately 50% of all types of cancer in Sudanese women. In a previous preliminary proteomic study aimed to identify proteins that were differentially expressed between tumors and control tissues (n=24), we identified peroxiredoxin V (PrdxV) as a candidate tumor marker. Peroxiredoxins (Prdxs) are a family of multifunctional proteins that are involved in the cell protection against oxidative stress, modulation of intracellular signaling, and regulation of cell proliferation.

View Article and Find Full Text PDF

Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway.

Free Radic Biol Med

December 2013

Dental Science Research Institute and the BK21 Project, Medical Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, 500-757, Republic of Korea. Electronic address:

Mammalian peroxiredoxin V (PrdxV) is a multifunctional protein that protects cells from DNA damage and inhibits stress-induced apoptosis. However, PrdxV is also known to be involved in modulating lipopolysaccharide (LPS)-induced host cell signaling, but its precise role is not fully understood. In this study, we used stably transfected RAW264.

View Article and Find Full Text PDF

The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell death.

Oncol Res

April 2012

Department of Biochemistry, Dental Science Research Institute, The 2nd Stage of Brain Korea 21 for Dental School, Chonnam National University, Gwangju, South Korea.

(-)-Epigallocatechin 3-gallate (EGCG) is a potent antioxidant polyphenol in green tea that acts as an anticancer agent via both direct and indirect pathways. Although the relationship between EGCG's anticancer effects and its antioxidant activity is not fully understood, it is known that EGCG stimulates production of reactive oxygen species (ROS), which induce oxidative stress leading to cell death. In IM9 multiple myeloma cells, EGCG acted in a dose- and time-dependent manner to induce apoptotic cell death.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!